Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Tandem Diabetes Care, Inc. - Common Stock (NQ: TNDM )

33.47 +0.86 (+2.64%)
Streaming Delayed Price Updated: 4:00 PM EST, Feb 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Tandem Diabetes Care, Inc. - Common Stock

< Previous 1 2 3 4 5 6 Next >
Tandem Diabetes Care Announces Upcoming Conference Presentations
From Tandem Diabetes Care, Inc.
Via Business Wire
Tandem Diabetes Care to Announce Fourth Quarter and Full Year 2024 Financial Results on February 26, 2025
From Tandem Diabetes Care, Inc.
Via Business Wire
Tandem Diabetes Care Enters Multi-Year Research Collaboration with UVA Center for Diabetes Technology for Development of Advanced Insulin Delivery Systems
From Tandem Diabetes Care, Inc.
Via Business Wire
Tandem t:slim X2 Insulin Pump Now Compatible with Dexcom G7 CGM in Canada
From Tandem Diabetes Care, Inc.
Via Business Wire
Tandem Diabetes Care Announces Upcoming Conference Presentations
From Tandem Diabetes Care, Inc.
Via Business Wire
Tandem Diabetes Care Announces Third Quarter 2024 Financial Results and Increases Full Year 2024 Sales Guidance
From Tandem Diabetes Care, Inc.
Via Business Wire
Tandem Diabetes Care Announces Upcoming Conference Participation
From Tandem Diabetes Care, Inc.
Via Business Wire
Tandem Diabetes Care to Announce Third Quarter 2024 Financial Results on November 6, 2024
From Tandem Diabetes Care, Inc.
Via Business Wire
Tandem t:slim X2 Insulin Pump Now Compatible with Lyumjev Ultra-rapid Acting Insulin in European Union
From Tandem Diabetes Care, Inc.
Via Business Wire
Tandem Diabetes Care Announces Upcoming Conference Participation
From Tandem Diabetes Care, Inc.
Via Business Wire
Tandem Diabetes Care to Release Updated iOS t:connect Mobile App for t:slim X2 Insulin Pump Users Impacted by March 2024 Nationwide Recall
From Tandem Diabetes Care, Inc.
Via Business Wire
Tandem Diabetes Care Provides Update on March 2024 Nationwide Recall of t:connect Mobile App for iOS Devices
From Tandem Diabetes Care, Inc.
Via Business Wire
TANDEM ALERT: Bragar Eagel & Squire, P.C. is Investigating Tandem Diabetes Care, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Tandem Diabetes Care Announces Second Quarter 2024 Financial Results and Increases Full Year 2024 Sales Guidance
From Tandem Diabetes Care, Inc.
Via Business Wire
Tandem Diabetes Care Announces Upcoming Conference Presentation
From Tandem Diabetes Care, Inc.
Via Business Wire
Tandem Diabetes Care and Dexcom Announce the t:slim X2 Insulin Pump with Dexcom G7 CGM Compatibility is Authorized for Sale by Health Canada
From Tandem Diabetes Care, Inc.
Via Business Wire
Tandem Diabetes Care to Announce Second Quarter 2024 Financial Results on August 1, 2024
From Tandem Diabetes Care, Inc.
Via Business Wire
Tandem Mobi Improves Quality of Life for People Living With Type 1 Diabetes in New Data Shared at American Diabetes Association Scientific Sessions
From Tandem Diabetes Care, Inc.
Via Business Wire
Tandem Diabetes Care Appoints Jean-Claude Kyrillos as Chief Operating Officer
From Tandem Diabetes Care, Inc.
Via Business Wire
Tandem Diabetes Care to Present New Early User Insights on the Tandem Mobi System at the American Diabetes Association’s 84th Scientific Sessions
From Tandem Diabetes Care, Inc.
Via Business Wire
Tandem Mobi Insulin Pump Now Compatible with Dexcom G7 CGM
From Tandem Diabetes Care, Inc.
Via Business Wire
Tandem Diabetes Care Announces Upcoming Conference Presentation
From Tandem Diabetes Care, Inc.
Via Business Wire
Tandem Diabetes Care Announces First Quarter 2024 Financial Results and Updates Full Year 2024 Financial Guidance
From Tandem Diabetes Care, Inc.
Via Business Wire
Tandem Diabetes Care Announces Upcoming Conference Presentations
From Tandem Diabetes Care, Inc.
Via Business Wire
TANDEM ALERT: Bragar Eagel & Squire, P.C. is Investigating Tandem Diabetes Care, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Tandem Diabetes Care to Announce First Quarter 2024 Financial Results on May 2, 2024
From Tandem Diabetes Care, Inc.
Via Business Wire
Parexel Announces CEO Succession Plan
Chief Operating & Growth Officer Peyton Howell to succeed Jamie Macdonald effective May 15, 2024; Mr. Macdonald to retire as CEO and continue on the Board of Directors through Dec. 31, 2024 
From Parexel International LLC
Via GlobeNewswire
Tandem Diabetes Care Prices Upsized Private Placement of $275.0 Million of Convertible Senior Notes Due 2029
From Tandem Diabetes Care, Inc.
Via Business Wire
Tandem Diabetes Care Announces Proposed Private Placement of Convertible Notes
From Tandem Diabetes Care, Inc.
Via Business Wire
Tandem Diabetes Care Inc. (NASDAQ: TNDM) Making Surprising Moves in Thursday Session
Via Investor Brand Network
< Previous 1 2 3 4 5 6 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.